Salvia
alpha 301 and alpha 302 clinical IPPB devices for secretion management, recruitment and drug nebulization

alpha 301 / 302

Respiratory therapy with intermittent positive pressure breathing (IPPB therapy) is a recognized treatment concept for obstructive respiratory disease. In case of heavily reduced ventilation reserves or pronounced respiratory failure, it is recommended to administer aerosols through inhalation. The slow, deep inspiration supported by the respiratory therapy device always improves pulmonary ventilation, gas exchange, and aerosol deposition. The optional, adjustable exhalation stricture contributes to this as well by ensuring that poorly ventilated peripheral lung segments receive a better gas supply. This in turn has prophylactic effects, since good ventilation is the best preventative measure against infection. Furthermore, IPPB therapy can be supplemented with drug nebulization, such as bronchospasmolytic or secretolytic substances, for obstructive diseases.

Managing secretion in intensive care and general care units, anethesia and IMC

Another positive effect of IPPB therapy is the cough reflex it provokes, which can significantly improve the bronchial hygiene and secretolysis of patients. In addition to portable respiratory and aerosol therapy devices for home care, the alpha product family also includes two clinical versions, which are designed to administer oxygen via a central gas supply. As a consequence, the devices are perfectly suited to provide continued IPPB therapy for recruitment, secretion management, and drug nebulization in acute care as well as physiotherapy and general care. For home use, the alpha product family includes a portable respiratory and aerosol therapy device: alpha 300.

Application areas of the alpha 301 and alpha 302 IPPB therapy devices:

  • Application in intensive care units, IMC, general care units and in anethesia
  • Suitable for applications involving IPPB therapy
alpha 301 alpha 302
Supply voltage 230 VAC, 50 Hz 230 VAC, 50 Hz
Power consumption 24 VA 150 W
Pressure range AIR 200 - 600 kPa (30 - 87 PSI) Internal compressor
Pressure range O2 270 - 600 kPa (40 - 87 PSI) 270 - 600 kPa (40 - 87 PSI)
Connection NIST NIST
Width x depth x height 265 x 165 x 260 mm 265 x 165 x 260 mm
Weight 5 kg 7 kg
Device class according to directive 93/42/EWG, Appendix IX II a II a
Safety class, electrical hazard II II
Airway pressure 5 - 40 hPa 5 - 40 hPa
Max. inspiration flow 15 - 60 L/Min 15 - 60 L/Min
Nebulizer option available available
Infinitely adjustable exhalation stricture available available
Manual control option available available

No liability for technical specifications

SALVIA medical does not accept liability for the accuracy, comprehensive nature or current validity of the technical product specifications. SALVIA medical reserves the right to changes these product specifications. Please contact: info@salvia-medical.de for binding information on our product specifications.

Advantages of the alpha 301 and alpha 302 IPPB therapy devices:

  • Sensitive trigger range
  • Integrated drug nebuliser
  • Compact IPPB device for adult and pediatric use
  • Infinitely adjustable exhalation stricture
  • Manual control option
  • Operation with central gas supply
  • Optional oxygen connection
alpha 301 and alpha 302 clinical IPPB devices for secretion management, recruitment and drug nebulization

Newsletter

CONTACT

SALVIA medical GmbH & Co. KG
Niederhöchstädter Str. 62
61476 Kronberg / GERMANY

T +49 (0) 6173 9333-0
F +49 (0) 6173 9333-29

info(at)salvia-medical.de